Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Enzo Life Sciences Methotrexate (1g). CAS: 133073-73-1
Folic acid antagonist. Potent inhibitor of dihydrofolate reductase. Induces apoptosis. Inhibits DNA synthesis. Anticancer agent. Alternative name: (+)-Amethopterin, 4-Amino-10-methylfolic acid, Methylaminopterin, MTX. Purity: ≥98% (HPLC). Appearance: Yellow powder. Solubility: Soluble in alkaline solution; insoluble in water, 100% ethanol or ether. Long Term Storage: +4°C.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Human immunoglobulin for electrophoresis BRP European Pharmacopoeia (EP) Reference Standard | 9007-83-4 |
Human immunoglobulin for electrophoresis BRP European Pharmacopoeia (EP) Reference Standard | 9007-83-4 |
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Galantamine natural for system suitability European Pharmacopoeia (EP) Reference Standard | 1953-04-4 | MFCD26142877 |
Galantamine natural for system suitability European Pharmacopoeia (EP) Reference Standard | Mol Wt: 368.27 | 1953-04-4 | MFCD26142877 |
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Simethicone United States Pharmacopeia (USP) Reference Standard | 8050-81-5 | 50G
Simethicone United States Pharmacopeia (USP) Reference Standard | 8050-81-5 | 50G
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Almotriptan Related Compound D United States Pharmacopeia (USP) Reference Standard | 603137-43-5 (free base) | 15MG
Almotriptan Related Compound D United States Pharmacopeia (USP) Reference Standard | Mol Wt: 387.92 | 603137-43-5 (free base) | 15MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Ramipril impurity C European Pharmacopoeia (EP) Reference Standard | 99742-35-5 |
Ramipril impurity C European Pharmacopoeia (EP) Reference Standard | Mol Wt: 422.56 | 99742-35-5 |
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Butalbital solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant(R) | Mol Wt: 224.26 | 77-26-9 | MFCD00056089 | 1ML
Butalbital solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant(R) | 77-26-9 | MFCD00056089 | 1ML
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Plastic additive 6 United States Pharmacopeia (USP) Reference Standard | 27676-62-6 | MFCD00134700 | 200MG
Plastic additive 6 United States Pharmacopeia (USP) Reference Standard | Mol Wt: 784.08 | 27676-62-6 | MFCD00134700 | 200MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Cabamiquine succinate | 2444781-71-7 | 99.8% | 580.65 g·mol-1 | C31H37FN4O6 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Cabamiquine succinate is the succinate salt of cabamiquine (DDD107498), an orally active antimalarial research compound. Supplied as a 10 mM solution in DMSO in a 1 mL vial, the product is intended for in vitro pharmacology and antimalarial studies. Handle according to the safety data sheet and institutional guidelines.
- Supplied as a 10 mM solution in DMSO.
- High purity (99.8%) suitable for research use.
- Succinate salt form of cabamiquine.
- Molecular weight 580.65 g·mol-1 and formula C31H37FN4O6.
- Intended for in vitro antimalarial and pharmacology studies.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Doxazosin | 74191-85-8 | MFCD00800482 | 99.9% | 451.48 | C23H25N5O5 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Doxazosin is a quinazoline-derived selective antagonist of postsynaptic α1-adrenergic receptors used in pharmacological research. Supplied as a white to off-white solid and available as a DMSO solution, it is provided for research use with defined purity and molecular identity.
- Selective α1-adrenergic receptor antagonist for pharmacology studies.
- Quinazoline derivative with defined chemical identity (CAS 74191-85-8).
- Available as a solid and as a DMSO solution for assay flexibility.
- High purity suitable for research applications.
- Molecular formula C23H25N5O5 and molecular weight 451.48 g/mol.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences D-Camphor sulfonic acid United States Pharmacopeia (USP) Reference Standard | 3144-16-9 | MFCD00064157 | 100MG
D-Camphor sulfonic acid United States Pharmacopeia (USP) Reference Standard | Mol Wt: 232.3 | 3144-16-9 | MFCD00064157 | 100MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Milbemycin oxime European Pharmacopoeia (EP) Reference Standard | 129496-10-2 |
Milbemycin oxime European Pharmacopoeia (EP) Reference Standard | 129496-10-2 |
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Med Vet International Suction Unit Disposable Container Filter Cartridge Vacu-Aide, 7305D-635, 12/Pack
Replacement part for Vacu-Aide Suction Machine
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Naproxen etemesil | 385800-16-8 | 99.89% | 336.40 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Naproxen etemesil is a lipophilic, non-acidic, inactive proagent of naproxen that is hydrolyzed to pharmacologically active Naproxen once absorbed. Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively, in cell assay. It is for research use only.
- Lipophilic, non-acidic, inactive prodrug of naproxen
- Hydrolyzed to pharmacologically active Naproxen upon absorption
- Inhibits COX-1 and COX-2 with IC50s of 8.72 μM and 5.15 μM, respectively, in cell assay
- Exerts anti-inflammatory and antifibrotic effects in a mouse model of bleomycin-induced lung fibrosis
- Downregulates TGF-β levels and Smad3/4 complex formation
- Inhibits inflammatory pain, fever, and PGE2 synthesis
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Keto-itraconazole | 112560-33-5 | MFCD08063772 | 98.4% | 719.62 g/mol | C35H36Cl2N8O5 | 1 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Keto-itraconazole is a metabolic derivative of itraconazole that acts as a potent inhibitor of cytochrome P450 3A (CYP3A). It is provided as an analytical-grade research reagent for in vitro enzyme inhibition and metabolism studies. Molecular formula: C35H36Cl2N8O5; molecular weight: ~719.6 g/mol; typical purity: 98.4%.
- Potent CYP3A inhibitor with reported unbound IC50 ≈ 4.6 nM.
- Intended for in vitro enzyme inhibition and metabolism research.
- High reported purity suitable for analytical experiments.
- Available in small quantities for screening and mechanistic studies.
- Provided as a solid; consult the safety data sheet for handling and storage.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More